Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of Tumor Treating Fields (TTFields) Concomitant With Radiosurgery for the Treatment of Recurrent, Bevacizumab-naïve Glioblastoma

NCT04671459 is registered in ClinicalTrials.gov with Prof. Franciszek Lukaszczyk Memorial Oncology Center as lead sponsor.

NCT NCT04671459
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04671459 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of Tumor Treating Fields (TTFields) Concomitant With Radiosurgery for the Treatment of Recurrent, Bevacizumab-naïve Glioblastoma
Lead sponsor
Prof. Franciszek Lukaszczyk Memorial Oncology Center
Phase
Phase 2
Overall status
Unknown status
Start date
December 26, 2020
Completion date
December 9, 2024
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma multiforme, recurrent glioblastoma